Bristol-Myers Squibb | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
AbbVie USD 5.52B 1.73B 2024-12
Abbott USD 6.53B 1.08B 2025-03
ALKERMES USD 399.81M 108.66M 2025-03
Amgen USD 8.81B 3.16B 2025-03
AstraZeneca USD 5.23B 258M 2025-03
Biogen USD 2.6B 223.3M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Drreddys Laboratories INR 1.1B 743M 2024-12
Eli Lilly USD 3.09B 175.1M 2025-03
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
J&J USD 38.47B 32.35B 2025-03
Medtronic USD 2.22B 978M 2025-04
Merck USD 8.63B 4.61B 2025-03
Novartis USD 8.87B 4.74B 2024-12
Novo Nordisk A/S 12.65B 15.81B 2022-12
Perrigo USD 409.9M 148.9M 2025-03
Pfizer USD 1.43B 387M 2025-03
Prestige Brands USD 97.88M 47.01M 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 7.99B 550M 2025-03
Sanofi 7.44B 646M 2024-12
United Therapeutics USD 1.9B 202.7M 2025-03
Zoetis USD 1.72B 264M 2025-03



Bristol-Myers Squibb Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.